1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Andon Health Co., Ltd.

Andon Health Co., Ltd.

002432.SZ
Andon Health Co., Ltd.CN flagShenzhen Stock Exchange
58.36
CNY
-1.25
- -
27.19BMarket Cap
Andon Health Co., Ltd.
002432.SZ
(Shenzhen Stock Exchange)

Recent

price

58.36

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.92
0.91
1.02
0.89
1.25
1.08
1.16
1.37
1.33
1.59
4.64
5.27
57.68
7.27
5.92
3.15
4.55
Revenue per Share
0.07
0.05
0.02
-0.02
0.03
-0.41
0.04
-0.38
0.03
0.15
0.56
2
35.14
2.81
3.81
5.23
4.51
Basic EPS, GAAP
-0.14
-0.21
-0.11
-0.29
-0.37
-0.44
-0.29
-0.34
-0.67
-0.24
0.94
0.49
39.48
3.5
2.09
-0.99
-0.26
Free Cash Flow per Basic Share
- -
0.06
0.07
- -
0.01
0.03
0.01
0.03
0.01
0.02
0.02
0.08
0.71
2.67
0.44
0.43
0.4
Dividend per Share
0.68
0.87
0.92
0.94
1.3
0.77
0.99
0.48
0.62
0.74
1.31
3.21
37.34
38.46
42.61
47.89
44.15
Book Value per Share
2.29
1.88
2.02
1.48
2
1.44
2.53
1.59
2.25
2.41
3.29
5.38
43.35
44.37
48.94
50.63
49.77
Tangible Book Value per Share
323
390
349
458
340
368
362
436
423
443
433
455
456
445
438
433
441
Basic Weighted Avg Shares
299
354
356
408
425
398
420
598
564
706
2,008
2,397
26,315
3,231
2,592
1,366
2,007
Sales/Revenue/Turnover
6.25
2.79
-2.18
-3.83
-19.51
-32.66
-33
-29.09
-20.27
-22.53
23.06
40.12
70.97
26.36
27.26
-21.72
5.02
Operating Margin (%)
4
6
7
11
21
25
35
47
55
60
63
89
106
105
66
74
- -
Depreciation Expense
24
21
7
-9
10
-151
14
-166
13
66
242
909
16,030
1,252
1,669
2,267
1,987
Net Income, GAAP
13.4
14.64
- -
- -
15.45
- -
- -
- -
- -
- -
1.22
6.53
9.72
14.62
14.56
10.2
10.09
Effective Tax Rate (%)
7.94
5.88
1.96
-2.25
2.4
-37.89
3.45
-27.74
2.25
9.41
12.07
37.91
60.92
38.74
64.38
165.99
99.03
Profit Margin (%)
665
615
559
489
456
290
998
424
675
923
1,155
1,821
12,396
10,470
11,517
7,426
11,010
Working Capital
- -
- -
- -
- -
- -
- -
306
- -
73
198
176
34
30
314
1,201
1,478
950
LT Debt
780
776
758
748
759
609
1,542
1,369
1,565
1,599
1,822
2,836
20,025
19,824
21,491
22,035
22,040
Total Equity
3.36
1.08
- -
- -
-8.26
- -
- -
- -
- -
- -
22.54
32.21
142.63
3.48
2.61
-1.01
0.36
Return on Invested Capital (%)
12.42
7.46
- -
- -
2.88
- -
- -
- -
- -
- -
36.15
65.15
158.78
6.28
7.59
9.58
8.75
Return on Capital (%)
12.22
7.45
2.12
-2.44
2.33
-41.53
4.51
-58.2
5.37
22.5
54.1
89.68
173.35
7.33
9.34
11.51
10.72
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
2,158
3,001
4,227
LT Borrowings
1,177
613
923
LT Finance Leases
24
22
27
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
493
473
474
Market Capitalization
18,115
18,531
16,058

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
14,077
14,276
15,536
Cash, Cash Equivalents & STI
10,452
10,218
11,431
Accounts Receivable, Net
57
80
57
Inventories
220
158
147
Total Current Liabilities
2,560
3,236
4,526
Payables & Accruals
- -
- -
- -
ST Debt
2,158
3,001
4,227
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
84.4%
134.32%
2.53%
Free Cash Flow
720.6%
1,532.56%
-147.23%
Net Income, GAAP
114.33%
383.23%
35.84%
Sales/Revenue/Turnover
111.42%
172.47%
-47.32%
Total Cash Common Dividend
147.18%
282.04%
-1.97%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
762
589
741
500
2,592
2025
507
258
296
- -
1,366
2026
301
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.56
- -
- -
- -
3.81
2025
0.6
- -
- -
- -
5.23
2026
0.7
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.44
2025
0.03
- -
- -
- -
0.43
2026
0.04
- -
- -
- -
- -
Similar Companies
Prim, S.A. (PRM.MC)
Lagis Enterprise Co., Ltd. (6730.TWO)
Chimin Health Management Co., Ltd. (603222.SS)
Sartorius AG (SRT.DE)
Nakanishi Inc. (7716.T)
HOYA Corporation (7741.T)
Business
Andon Health Co., Ltd. (002432.SZ) researches, develops, manufactures, and sells health electronics, smart hardware, and medical instruments principally for home use; its core products encompass blood pressure monitors, blood glucose meters, thermometers, pulse oximeters, nebulizers, TENS units, massagers, body fat scales, pregnancy rapid tests, fetal heart rate meters, COVID-19 test kits, nasal irrigators, insect bite healers, red light allergy relievers, and wearable devices tracking blood oxygen, ECG, heart rate, weight, body fat, sleep, and exercise under brands including iHealth, alongside original design manufacturer/original equipment manufacturer offerings and mobile medical communications equipment. Founded in 1995 and headquartered in Tianjin, China, the company operates globally through subsidiaries in Silicon Valley, Paris, Beijing, and Singapore, serving domestic and overseas markets in personal health management, chronic disease monitoring, and smart healthcare via an integrated platform of hardware, mobile applications, and cloud services. In February 2025, its wholly-owned subsidiary Andon Hong Kong completed the acquisition of the remaining 20% stake in iHealth Inc. from Xiaomi Investment for $45.91 million, achieving 100% ownership and enhancing control over its key overseas brand and IVD expansion including diabetes management solutions; additionally, in August 2025, Andon Health led a Series A+ strategic investment in Chromai Technologies to bolster capabilities in high-end scientific instrumentation such as ultra-high-performance liquid chromatography systems.